Status:
COMPLETED
The Bioavailability of Multiple Novel, Sustainable, Non-animal Derived Protein Sources
Lead Sponsor:
University of Exeter
Conditions:
Healthy Aging
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The progressive age-related loss of muscle mass is termed sarcopenia. Consequences of sarcopenia are, but not limited to, decreased muscle strength, frailty, and an increased risk for the development ...
Eligibility Criteria
Inclusion
- Males and females aged 18-35 or 55 - 80 years old.
- Body mass index between 18.5 - 30.
Exclusion
- Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes).
- Any diagnosed cardiovascular disease or hypertension.
- Elevated blood pressure (\>150/90 mmHg) at the time of screening.
- Known pre-existing liver disease/condition.
- Any medication known to affect protein and/or amino acid metabolism.
- Allergy to mycoprotein/Quorn/edible fungi, edible algae, lupin/legumes, or milk.
- Smoking.
Key Trial Info
Start Date :
November 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04297137
Start Date
November 12 2019
End Date
October 1 2022
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Exeter
Exeter, United Kingdom